Cited by 68Gestational Diabetes Research and ManagementBirth, Development, and HealthFatty Acid Research and Health

Implications of Lipids in Neonatal Body Weight and Fat Mass in Gestational Diabetic Mothers and Non-Diabetic Controls

Herrera, Emilio, Ortega-Senovilla, Henar·2018·Current Diabetes Reports

Abstract

Purpose of review Maternal lipid metabolism greatly changes during pregnancy and we review in this article how they influence fetal adiposity and growth under non-diabetic and gestational diabetic conditions. Recent findings In pregnant women without diabetes (control), maternal glycemia correlates with neonatal glycemia, neonatal body weight and fat mass. In pregnant women with gestational diabetes mellitus (GDM), maternal glucose correlates with neither neonatal glycemia, neonatal birth weight nor fat mass, but maternal triacylglycerols (TAG), non-esterified fatty acids (NEFA) and glycerol do correlate with birth weight and neonatal adiposity. The proportions of maternal plasma arachidonic (AA) and docosahexaenoic (DHA) acids decrease from the first to the third trimester of pregnancy, and at term these long-chain polyunsaturated fatty acids are higher in cord blood plasma than in mothers, indicating efficient placental transfer. In control or pregnant women with GDM at term, the maternal concentration of individual fatty acids does not correlate with neonatal body weight or fat mass, but cord blood fatty acid levels correlate with birth weight and neonatal adiposity-positively in controls, but negatively in GDM. The proportion of AA and DHA in umbilical artery plasma in GDM is lower than in controls but not in umbilical vein plasma. Therefore, an increased utilization of those two fatty acids by fetal tissues, rather than impaired placental transfer, is responsible for their smaller proportion in plasma of GDM newborns. In control pregnant women, maternal glycemia controls neonatal body weight and fat mass, whereas in mothers with GDM-even with good glycemic control-maternal lipids and their greater utilization by the fetus play a critical role in neonatal body weight and fat mass. We propose that altered lipid metabolism rather than hyperglycemia constitutes a risk for macrosomia in GDM.

Integrity signals

Registry

Crossref · 10.1007/s11892-018-0978-4

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Herrera, E., & Ortega-Senovilla, H.
Venue
Current Diabetes Reports
Published
2018-02
Volume
18
Issue
2
Pages
7-7
ISSN
  • 1534-4827 (ISSN-L)
  • 1539-0829
OpenAlex
W2789642184
Cited by
68
References
12
Citations by year
2026: 4 · 2025: 3 · 2024: 6 · 2023: 2 · 2022: 10 · 2021: 26 · 2020: 10 · 2019: 7
FWCI
1.74
Type
journal article
Language
en
Open access
closed
Locations
  • Current Diabetes Reports (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Fundación Ramón Areces
  • Ministerio de Economía y Competitividad
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
Keywords
gestational diabetes mellitus, neonatal body weight, neonatal fat mass, fetal adiposity, maternal lipid metabolism, triglycerides, free fatty acids, glycerol, arachidonic acid, docosahexaenoic acid, long-chain polyunsaturated fatty acids, placental transfer, umbilical cord blood, macrosomia, maternal glycemia
MeSH terms
Birth Weight, Female, Humans, Infant, Newborn, Lipids, Mothers, Pregnancy, Case-Control Studies, Diabetes, Gestational, Adiposity, Lipid Metabolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review